Advanced
  Home Compare Reports

Comparison with Similar Reports

Veterinary Diagnostics Market by Product(Instruments, Consumables), Technology (Immunodiagnostics (Lateral Flow, ELISA), Clinical Biochemistry, PCR, H...

Publisher:        MarketsandMarkets

# of Pages:        413

Rating: 

1 User License $4,950

Publication Date:  June, 2021

Price:       $4,950 / User License




1 INTRODUCTION 54
1.1 OBJECTIVES OF THE STUDY 54
1.2 MARKET DEFINITION & SCOPE 54
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 54
1.2.2 MARKETS COVERED 55
1.2.3 YEARS CONSIDERED FOR THE STUDY 56
1.3 CURRENCY 56
TABLE 1 EXCHANGE RATES UTILIZED FOR THE CONVERSION TO USD 56
1.4 LIMITATIONS 56
1.5 STAKEHOLDERS 57
1.6 SUMMARY OF CHANGES 57
2 RESEARCH METHODOLOGY 59
2.1 RESEARCH DATA 59
FIGURE 1 RESEARCH DESIGN 59
2.1.1 SECONDARY DATA 59
2.1.1.1 Key data from secondary sources 61
2.1.2 PRIMARY DATA 61
FIGURE 2 PRIMARY SOURCES 61
2.1.2.1 Key data from primary sources 62
2.1.2.2 Key industry insights 63
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS (VETERINARY DIAGNOSTICS MARKET) 63
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE PARTICIPANTS,
BY COMPANY TYPE, DESIGNATION, AND REGION 64
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: DEMAND-SIDE PARTICIPANTS,
BY END USER, DESIGNATION, AND REGION 64
2.2 MARKET SIZE ESTIMATION 65
FIGURE 6 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 65
FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION: IDEXX LABORATORIES, INC. 66
FIGURE 8 SUPPLY-SIDE ANALYSIS OF THE TOP COMPANIES: COMPANION DIAGNOSTICS MARKET (2020) 67
FIGURE 9 SUPPLY-SIDE ANALYSIS OF THE TOP COMPANIES: LIVESTOCK DIAGNOSTICS MARKET (2020) 68
FIGURE 10 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE VETERINARY DIAGNOSTICS MARKET (2021–2026) 69
FIGURE 11 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 69
FIGURE 12 TOP-DOWN APPROACH 70
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 71
FIGURE 13 MARKET DATA TRIANGULATION METHODOLOGY 71
2.4 MARKET SHARE ANALYSIS 72
2.5 ASSUMPTIONS FOR THE STUDY 72
2.6 RISK ASSESSMENT 73
TABLE 2 RISK ASSESSMENT: VETERINARY DIAGNOSTICS MARKET 73
3 EXECUTIVE SUMMARY 74
FIGURE 14 VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,
2021 VS. 2026 (USD MILLION) 74
FIGURE 15 VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,
2021 VS. 2026 (USD MILLION) 75
FIGURE 16 VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2021 VS. 2026 (USD MILLION) 75
FIGURE 17 VETERINARY DIAGNOSTICS MARKET, BY END USER,
2021 VS. 2026 (USD MILLION) 76
FIGURE 18 GEOGRAPHICAL SNAPSHOT OF THE VETERINARY DIAGNOSTICS MARKET 77
4 PREMIUM INSIGHTS 78
4.1 VETERINARY DIAGNOSTICS MARKET OVERVIEW 78
FIGURE 19 GROWING PREVALENCE OF ZOONOTIC DISEASES TO DRIVE MARKET GROWTH 78
4.2 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY END USER AND COUNTRY (2020) 79
FIGURE 20 VETERINARY REFERENCE LABORATORIES SEGMENT ACCOUNTED FOR
THE LARGEST SHARE OF THE APAC MARKET IN 2020 79
4.3 VETERINARY DIAGNOSTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 80
FIGURE 21 CHINA TO REGISTER THE HIGHEST GROWTH IN THE VETERINARY DIAGNOSTICS MARKET DURING THE FORECAST PERIOD 80
5 MARKET OVERVIEW 81
5.1 INTRODUCTION 81
5.2 MARKET DYNAMICS 81
FIGURE 22 VETERINARY DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 81
5.2.1 MARKET DRIVERS 82
5.2.1.1 Growth in the companion animal population 82
TABLE 3 PET POPULATION, BY ANIMAL, 2014–2018 (MILLION) 83
5.2.1.2 Rising demand for animal-derived food products 83
TABLE 4 PAST AND PROJECTED TRENDS IN THE CONSUMPTION OF MEAT AND MILK IN DEVELOPED AND DEVELOPING COUNTRIES 83
FIGURE 23 ASIA: COUNTRY-LEVEL CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2020 VS. 2030 (THOUSAND METRIC TONS) 84
FIGURE 24 ASIA: COUNTRY-LEVEL PRODUCTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2020 VS. 2030 (THOUSAND METRIC TONS) 84
FIGURE 25 ASIA WAS THE HIGHEST CONSUMER OF MEAT AND MILK IN 2018 84
5.2.1.3 Increasing incidence of transboundary and zoonotic diseases 85
TABLE 5 ANIMAL DISEASE OUTBREAKS IN ASIA PACIFIC COUNTRIES (2009–2019) 85
5.2.1.4 Rising demand for pet insurance and growing animal health expenditure 86
TABLE 6 AVERAGE PREMIUMS PAID IN THE US, 2019 VS. 2020 86
FIGURE 26 US: PET INDUSTRY EXPENDITURE, 2010–2019 87
5.2.1.5 Growing number of veterinary practitioners & their rising income levels in developed economies 88
TABLE 7 NUMBER OF VETERINARIANS AND PARAVETERINARIANS IN DEVELOPED COUNTRIES, 2012–2018 88
TABLE 8 MARKET DRIVERS: IMPACT ANALYSIS 89
5.2.2 MARKET RESTRAINTS 89
5.2.2.1 Rising pet care costs 89
TABLE 9 MARKET RESTRAINTS: IMPACT ANALYSIS 89
5.2.3 MARKET OPPORTUNITIES 90
5.2.3.1 Increased use of PCR testing panels to rule out COVID-19 virus in animals 90
5.2.3.2 Untapped emerging markets 90
TABLE 10 MARKET OPPORTUNITIES: IMPACT ANALYSIS 91
5.2.4 MARKET CHALLENGES 91
5.2.4.1 Shortage of veterinary practitioners in developing markets 91
TABLE 11 NUMBER OF VETERINARY PROFESSIONALS, BY COUNTRY, 2005 VS. 2014 VS. 2018 91
TABLE 12 MARKET CHALLENGES: IMPACT ANALYSIS 92
5.3 INDUSTRY TRENDS 92
5.3.1 ADOPTION OF MULTIPLE TESTING PANELS 92
TABLE 13 MULTIPLE TESTING PANELS VS. SINGLE TESTING PANELS 92
5.3.2 OUTSOURCING OF VETERINARY DIAGNOSTIC TESTING SERVICES 92
5.3.3 GROWING CONSOLIDATION IN THE VETERINARY DIAGNOSTICS INDUSTRY 93
TABLE 14 MAJOR ACQUISITIONS IN THE ANIMAL HEALTH DIAGNOSTICS INDUSTRY 93
5.4 DISEASE TRENDS 94
5.4.1 LIVESTOCK 94
5.4.1.1 Avian influenza (AI) 94
5.4.1.2 African swine fever (ASF) 94
5.4.1.3 Bovine babesiosis (BB) 94
5.4.1.4 Peste des petits ruminants (PPR) 94
5.4.1.5 West Nile virus (WNV) 94
5.4.2 COMPANION ANIMALS 94
5.4.2.1 Zoonotic diseases 94
TABLE 15 COMMON ZOONOTIC DISEASES SPREAD BY COMPANION ANIMALS ACROSS THE GLOBE 95
5.4.2.2 Obesity & diabetes 96
5.5 TECHNOLOGICAL ANALYSIS 96
5.5.1 KEY TECHNOLOGY 96
5.5.1.1 Development of portable instruments for POC diagnostic services 96
TABLE 16 PONT-OF-CARE PORTABLE VETERINARY DIAGNOSTIC INSTRUMENTS 96
5.5.2 ADJACENT TECHNOLOGY 96
5.5.2.1 Development of rapid and sensitive veterinary diagnostic kits 96
5.6 PRICING ANALYSIS 97
TABLE 17 REGIONAL PRICING ANALYSIS OF VETERINARY ANALYZERS, 2019 (USD) 97
5.7 IMPACT OF COVID-19 ON THE VETERINARY DIAGNOSTICS MARKET 98
TABLE 18 GLOBAL SNAPSHOT OF THE REPORTED CASES OF NATURALLY ACQUIRED SARS-COV-2 (COVID-19) INFECTIONS IN ANIMALS 98
FIGURE 27 MONTHLY VETERINARY PRACTICE ACTIVITY, BY REGION, JANUARY–JUNE 2020 99
5.8 VALUE CHAIN ANALYSIS 99
FIGURE 28 VETERINARY DIAGNOSTICS MARKET: VALUE CHAIN ANALYSIS 100
5.9 ECOSYSTEM MARKET MAP 100
FIGURE 29 VETERINARY DIAGNOSTICS MARKET: ECOSYSTEM PARTICIPANTS 101
FIGURE 30 VETERINARY DIAGNOSTICS MARKET: ECOSYSTEM MARKET MAP 101
5.10 PORTER’S FIVE FORCES ANALYSIS 102
TABLE 19 VETERINARY DIAGNOSTICS MARKET: PORTER’S FIVE FORCES ANALYSIS 102
5.10.1 THREAT OF NEW ENTRANTS 102
5.10.2 THREAT OF SUBSTITUTES 103
5.10.3 BARGAINING POWER OF SUPPLIERS 103
5.10.4 BARGAINING POWER OF BUYERS 103
5.10.5 INTENSITY OF COMPETITIVE RIVALRY 103
5.11 SUPPLY CHAIN ANALYSIS 104
FIGURE 31 VETERINARY DIAGNOSTICS MARKET: SUPPLY CHAIN ANALYSIS 105
5.12 REGULATORY ANALYSIS 105
5.12.1 US 105
5.12.2 EUROPE 106
5.13 PATENT ANALYSIS 106
5.13.1 PATENT PUBLICATION TRENDS FOR VETERINARY DIAGNOSTICS 107
FIGURE 32 PATENT PUBLICATION TRENDS (JANUARY 2011–MAY 2021) 107
5.13.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 107
FIGURE 33 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR VETERINARY DIAGNOSTIC PATENTS (JANUARY 2011–MAY 2021) 108
FIGURE 34 TOP APPLICANT COUNTRIES/REGIONS FOR VETERINARY DIAGNOSTICS PATENTS (JANUARY 2011–MAY 2021) 109
6 VETERINARY DIAGNOSTICS MARKET, BY PRODUCT 110
6.1 INTRODUCTION 111
TABLE 20 VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 111
6.2 CONSUMABLES 111
6.2.1 CONSUMABLES ACCOUNTED FOR THE LARGEST SHARE OF THE VETERINARY DIAGNOSTIC PRODUCTS MARKET IN 2020 111
TABLE 21 KEY VETERINARY DIAGNOSTIC CONSUMABLES AVAILABLE IN THE MARKET (2020) 112
TABLE 22 VETERINARY DIAGNOSTIC CONSUMABLES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 113
6.3 INSTRUMENTS 113
6.3.1 INCREASE IN POINT-OF-CARE APPLICATIONS FOR EARLY DIAGNOSIS AND PRECISION IN LIVESTOCK FARMING TO DRIVE MARKET GROWTH 113
TABLE 23 KEY VETERINARY DIAGNOSTIC INSTRUMENTS AVAILABLE IN THE MARKET (2020) 114
TABLE 24 VETERINARY DIAGNOSTIC INSTRUMENTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 115
7 VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY 116
7.1 INTRODUCTION 117
TABLE 25 VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 117
TABLE 26 VETERINARY DIAGNOSTICS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 118
7.1.1 IMPACT OF COVID-19 ON THE TYPE OF TECHNOLOGIES USED 118
7.2 IMMUNODIAGNOSTICS 119
TABLE 27 KEY VETERINARY IMMUNODIAGNOSTIC PRODUCTS AVAILABLE IN THE MARKET 119
TABLE 28 VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 120
TABLE 29 VETERINARY IMMUNODIAGNOSTICS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 121
7.2.1 LATERAL FLOW ASSAYS 121
TABLE 30 LATERAL FLOW ASSAYS MARKET, BY TYPE, 2019–2026 (USD MILLION) 122
TABLE 31 LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 122
TABLE 32 LATERAL FLOW ASSAYS MARKET, BY REGION, 2019–2026 (MILLION UNITS) 123
7.2.1.1 Lateral flow rapid tests 123
7.2.1.1.1 Lateral flow rapid tests held the larger share of the lateral flow assays market 123
TABLE 33 LATERAL FLOW RAPID TESTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 124
7.2.1.2 Lateral flow strip readers 124
7.2.1.2.1 Lateral flow strip readers determine the quantity of analytes in the sample 124
TABLE 34 LATERAL FLOW STRIP READERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 125
7.2.2 ELISA TESTS 125
7.2.2.1 ELISA tests are quick, simple to perform, and cost-effective 125
TABLE 35 ELISA TESTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 126
TABLE 36 ELISA TESTS MARKET, BY REGION, 2019–2026 (THOUSAND UNITS) 126
7.2.3 ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS 127
7.2.3.1 Increasing incidence of allergic diseases in companion animals to drive market growth 127
TABLE 37 ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 127
7.2.4 IMMUNOASSAY ANALYZERS 128
7.2.4.1 Immunoassay analyzers are widely used for livestock 128
TABLE 38 IMMUNOASSAY ANALYZERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 128
7.2.5 OTHER IMMUNODIAGNOSTIC PRODUCTS 129
TABLE 39 OTHER IMMUNODIAGNOSTIC PRODUCTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 129
7.3 CLINICAL BIOCHEMISTRY 130
TABLE 40 KEY VETERINARY CLINICAL BIOCHEMISTRY PRODUCTS AVAILABLE IN THE MARKET 130
TABLE 41 VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2019–2026 (USD MILLION) 131
TABLE 42 VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 131
7.3.1 CLINICAL CHEMISTRY ANALYSIS 132
TABLE 43 CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 132
TABLE 44 CLINICAL CHEMISTRY ANALYSIS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 133
7.3.1.1 Clinical chemistry reagent clips and cartridges 133
7.3.1.1.1 Increasing pet healthcare expenditure and the rising number of screening tests performed to drive market growth 133
TABLE 45 CLINICAL CHEMISTRY REAGENT CLIPS & CARTRIDGES MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 134
7.3.1.2 Clinical chemistry analyzers 134
7.3.1.2.1 Increasing installations of clinical chemistry analyzers to drive market growth 134
TABLE 46 CLINICAL CHEMISTRY ANALYZERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 135
7.3.2 GLUCOSE MONITORING 135
TABLE 47 GLUCOSE MONITORING MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 136
TABLE 48 GLUCOSE MONITORING MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 136
7.3.2.1 Blood glucose strips 137
7.3.2.1.1 Blood glucose strips accounted for the largest share of the glucose monitoring market in 2020 137
TABLE 49 BLOOD GLUCOSE STRIPS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 137
7.3.2.2 Glucose monitors 138
7.3.2.2.1 Increasing incidence of diabetes in pet animals to drive the adoption of glucose monitors 138
TABLE 50 GLUCOSE MONITORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 138
7.3.2.3 Urine glucose strips 139
7.3.2.3.1 Increasing risk of developing DKA in animals to drive the market growth 139
TABLE 51 URINE GLUCOSE STRIPS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 139
7.3.3 BLOOD GAS & ELECTROLYTE ANALYSIS 140
TABLE 52 BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 140
TABLE 53 BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 140
7.3.3.1 Blood gas and electrolyte reagent clips and cartridges 141
7.3.3.1.1 Easy availability of animal species-specific preloaded reagent clips to support market growth 141
TABLE 54 BLOOD GAS & ELECTROLYTE REAGENT CLIPS & CARTRIDGES MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 141
7.3.3.2 Blood gas & electrolyte analyzers 142
7.3.3.2.1 Blood gas and electrolyte analyzers are used to determine the amount of oxygen and carbon dioxide in the blood 142
TABLE 55 BLOOD GAS & ELECTROLYTE ANALYZERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 142
7.4 MOLECULAR DIAGNOSTICS 143
TABLE 56 VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 143
TABLE 57 VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 144
7.4.1 POLYMERASE CHAIN REACTION (PCR) TESTS 144
7.4.1.1 Increased laboratory usage of PCR in proteomics and genomics to support market growth 144
TABLE 58 PCR TESTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 145
7.4.2 MICROARRAYS 145
7.4.2.1 Growing applications of biochips in the identification of infectious diseases to propel market growth 145
TABLE 59 MICROARRAYS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 146
7.4.3 OTHER MOLECULAR DIAGNOSTIC PRODUCTS 146
TABLE 60 OTHER MOLECULAR DIAGNOSTIC PRODUCTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 147
7.5 HEMATOLOGY 147
TABLE 61 KEY VETERINARY HEMATOLOGY PRODUCTS AVAILABLE IN THE MARKET 148
TABLE 62 VETERINARY HEMATOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 148
TABLE 63 VETERINARY HEMATOLOGY MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 149
7.5.1 HEMATOLOGY CARTRIDGES 149
7.5.1.1 Hematology cartridges are used along with hematology analyzers for complete blood analysis 149
TABLE 64 HEMATOLOGY CARTRIDGES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 150
7.5.2 HEMATOLOGY ANALYZERS 150
7.5.2.1 70% of veterinary hospitals and clinics are equipped with hematology analyzers as a basic diagnostic tool 150
TABLE 65 HEMATOLOGY ANALYZERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 151
TABLE 66 HEMATOLOGY ANALYZERS MARKET, BY REGION, 2019–2026 (UNITS) 151
7.6 URINALYSIS 152
TABLE 67 KEY VETERINARY URINALYSIS PRODUCTS AVAILABLE IN THE MARKET 152
TABLE 68 VETERINARY URINALYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 152
TABLE 69 VETERINARY URINALYSIS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 153
7.6.1 URINALYSIS CLIPS & CARTRIDGES/PANELS 153
7.6.1.1 Clips and cartridges are used in urine analyzers to detect single or multiple electrolytes or metabolites 153
TABLE 70 URINALYSIS CLIPS & CARTRIDGES/PANELS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 154
7.6.2 URINE ANALYZERS 154
7.6.2.1 Development of easy-to-use urine analyzers for POC testing to drive market growth 154
TABLE 71 URINE ANALYZERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 155
7.6.3 URINE TEST STRIPS 155
7.6.3.1 Rising occurrence of kidney diseases in cats and dogs to support the market growth 155
TABLE 72 URINE TEST STRIPS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 156
7.7 OTHER VETERINARY DIAGNOSTIC TECHNOLOGIES 156
TABLE 73 OTHER VETERINARY DIAGNOSTIC TECHNOLOGIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 157
8 VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE 158
8.1 INTRODUCTION 159
TABLE 74 VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2019–2026 (USD MILLION) 159
8.2 COMPANION ANIMALS 159
FIGURE 35 MARKET FOR DOGS TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD 160
TABLE 75 VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 160
TABLE 76 VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS,
BY COUNTRY, 2019–2026 (USD MILLION) 161
8.2.1 DOGS 161
8.2.1.1 Dogs dominate the veterinary diagnostics market for companion animals 161
TABLE 77 DOG POPULATION, BY COUNTRY, 2012–2019 (MILLION) 162
TABLE 78 VETERINARY DIAGNOSTICS MARKET FOR DOGS, BY COUNTRY,
2019–2026 (USD MILLION) 162
8.2.2 CATS 163
8.2.2.1 Increasing pet cat population to drive market growth 163
TABLE 79 CAT POPULATION, BY COUNTRY, 2012–2019 (MILLION) 163
TABLE 80 VETERINARY DIAGNOSTICS MARKET FOR CATS, BY COUNTRY,
2019–2026 (USD MILLION) 164
8.2.3 HORSES 164
8.2.3.1 Growing equine health awareness to drive market growth 164
TABLE 81 EQUINE POPULATION, BY COUNTRY, 2012–2019 (THOUSAND) 165
TABLE 82 VETERINARY DIAGNOSTICS MARKET FOR HORSES, BY COUNTRY,
2019–2026 (USD MILLION) 166
8.2.4 OTHER COMPANION ANIMALS 166
TABLE 83 VETERINARY DIAGNOSTICS MARKET FOR OTHER COMPANION ANIMALS,
BY COUNTRY, 2019–2026 (USD MILLION) 167
8.3 LIVESTOCK 167
TABLE 84 VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE,
2019–2026 (USD MILLION) 168
FIGURE 36 MARKET FOR CATTLE TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD 169
TABLE 85 VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY COUNTRY,
2019–2026 (USD MILLION) 169
8.3.1 CATTLE 170
8.3.1.1 Growing consumption of meat to support market growth 170
TABLE 86 CATTLE POPULATION, BY COUNTRY, 2012–2019 (MILLION) 170
TABLE 87 VETERINARY DIAGNOSTICS MARKET FOR CATTLE, BY COUNTRY,
2019–2026 (USD MILLION) 171
8.3.2 PIGS 171
8.3.2.1 Growing incidence of infectious diseases to drive market growth 171
TABLE 88 SWINE POPULATION, BY COUNTRY, 2012–2019 (MILLION) 172
FIGURE 37 PER CAPITA PORK CONSUMPTION, 2006–2018 (POUNDS) 172
TABLE 89 VETERINARY DIAGNOSTICS MARKET FOR PIGS, BY COUNTRY,
2019–2026 (USD MILLION) 173
8.3.3 POULTRY 173
8.3.3.1 Increasing demand for poultry meat to support the growth of the diagnostics market 173
FIGURE 38 PER CAPITA POULTRY MEAT CONSUMPTION, 2006–2018 (POUNDS) 174
TABLE 90 POULTRY POPULATION, BY COUNTRY, 2012–2019 (MILLION) 174
TABLE 91 VETERINARY DIAGNOSTICS MARKET FOR POULTRY, BY COUNTRY,
2019–2026 (USD MILLION) 175
8.3.4 OTHER LIVESTOCK 175
TABLE 92 VETERINARY DIAGNOSTICS MARKET FOR OTHER LIVESTOCK, BY COUNTRY, 2019–2026 (USD MILLION) 176
9 VETERINARY DIAGNOSTICS MARKET, BY END USER 177
9.1 INTRODUCTION 178
TABLE 93 VETERINARY DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION) 178
9.2 VETERINARY REFERENCE LABORATORIES 178
9.2.1 VETERINARY REFERENCE LABORATORIES ARE THE LARGEST END USERS OF VETERINARY DIAGNOSTICS 178
TABLE 94 VETERINARY DIAGNOSTICS MARKET FOR VETERINARY REFERENCE LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION) 179
9.3 VETERINARY HOSPITALS & CLINICS 179
9.3.1 INCREASING PET OWNERSHIP AND SPENDING ON PET CARE TO PROPEL MARKET GROWTH 179
TABLE 95 VETERINARY DIAGNOSTICS MARKET FOR VETERINARY HOSPITALS & CLINICS, BY COUNTRY, 2019–2026 (USD MILLION) 180
9.4 POINT-OF-CARE/IN-HOUSE TESTING 180
9.4.1 POINT-OF-CARE TESTING IS EASY-TO-USE, COST-EFFECTIVE, AND OFFERS SWIFT RESULTS 180
TABLE 96 VETERINARY DIAGNOSTICS MARKET FOR POINT-OF-CARE/IN-HOUSE TESTING, BY COUNTRY, 2019–2026 (USD MILLION) 181
9.5 VETERINARY RESEARCH INSTITUTES & UNIVERSITIES 182
9.5.1 INCREASING COLLABORATIONS BETWEEN PRIVATE COMPANIES AND VETERINARY RESEARCH INSTITUTES & UNIVERSITIES TO DRIVE MARKET GROWTH 182
TABLE 97 VETERINARY DIAGNOSTICS MARKET FOR VETERINARY RESEARCH INSTITUTES & UNIVERSITIES, BY COUNTRY, 2019–2026 (USD MILLION) 183
10 VETERINARY DIAGNOSTICS MARKET, BY REGION 184
10.1 INTRODUCTION 185
TABLE 98 VETERINARY DIAGNOSTICS MARKET, BY REGION,
2019–2026 (USD MILLION) 185
10.2 NORTH AMERICA 185
FIGURE 39 EXPECTED GROWTH IN THE NUMBER OF VETERINARIANS IN NORTH AMERICA 186
FIGURE 40 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET SNAPSHOT 187
TABLE 99 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 187
TABLE 100 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 188
TABLE 101 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 188
TABLE 102 NORTH AMERICA: VETERINARY IMMUNODIAGNOSTICS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 188
TABLE 103 NORTH AMERICA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2019–2026 (USD MILLION) 189
TABLE 104 NORTH AMERICA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2019–2026 (USD MILLION) 189
TABLE 105 NORTH AMERICA: VETERINARY CLINICAL CHEMISTRY ANALYSIS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 189
TABLE 106 NORTH AMERICA: VETERINARY GLUCOSE MONITORING MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 190
TABLE 107 NORTH AMERICA: VETERINARY BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 190
TABLE 108 NORTH AMERICA: VETERINARY MOLECULAR DIAGNOSTICS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 190
TABLE 109 NORTH AMERICA: VETERINARY HEMATOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 191
TABLE 110 NORTH AMERICA: VETERINARY URINALYSIS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 191
TABLE 111 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 191
TABLE 112 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 192
TABLE 113 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK,
BY TYPE, 2019–2026 (USD MILLION) 192
TABLE 114 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION) 192
10.2.1 US 193
10.2.1.1 The US dominated the North American veterinary diagnostics market in 2020 193
FIGURE 41 US: DOGS POPULATION, 2012–2020 (MILLION) 193
FIGURE 42 US: EXPENDITURE ON VET VISITS 193
TABLE 115 US: FOOD-PRODUCING ANIMAL POPULATION, 2001–2019 (MILLION) 194
FIGURE 43 NUMBER OF CATS AND DOGS TESTED POSITIVE FOR COVID-19 IN THE US, 2020 194
FIGURE 44 NUMBER OF VETERINARIANS IN THE US, 2014–2019 195
TABLE 116 US: NUMBER OF VETERINARIANS IN PRIVATE CLINICAL PRACTICES,
2014–2019 195
TABLE 117 US: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 196
TABLE 118 US: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 196
TABLE 119 US: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 196
TABLE 120 US: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE,
2019–2026 (USD MILLION) 197
TABLE 121 US: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2019–2026 (USD MILLION) 197
TABLE 122 US: VETERINARY CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 197
TABLE 123 US: VETERINARY GLUCOSE MONITORING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 198
TABLE 124 US: VETERINARY BLOOD GAS & ELECTROLYTE ANALYSIS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 198
TABLE 125 US: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 198
TABLE 126 US: VETERINARY HEMATOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 199
TABLE 127 US: VETERINARY URINALYSIS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 199
TABLE 128 US: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2019–2026 (USD MILLION) 199
TABLE 129 US: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS,
BY TYPE, 2019–2026 (USD MILLION) 200
TABLE 130 US: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE,
2019–2026 (USD MILLION) 200
TABLE 131 US: VETERINARY DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION) 200
10.2.2 CANADA 201
10.2.2.1 Growing pet adoption in Canada to drive market growth 201
FIGURE 45 CANADA: COMPANION ANIMAL POPULATION, 2016–2020 (MILLION) 201
TABLE 132 CANADA: LARGE ANIMAL POPULATION, 2001–2019 (MILLION) 201
TABLE 133 CANADA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 202
TABLE 134 CANADA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 202
TABLE 135 CANADA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 203
TABLE 136 CANADA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 203
TABLE 137 CANADA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2019–2026 (USD MILLION) 203
TABLE 138 CANADA: VETERINARY CLINICAL CHEMISTRY ANALYSIS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 204
TABLE 139 CANADA: VETERINARY GLUCOSE MONITORING MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 204
TABLE 140 CANADA: VETERINARY BLOOD GAS & ELECTROLYTE ANALYSIS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 204
TABLE 141 CANADA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 205
TABLE 142 CANADA: VETERINARY HEMATOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 205
TABLE 143 CANADA: VETERINARY URINALYSIS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 205
TABLE 144 CANADA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2019–2026 (USD MILLION) 206
TABLE 145 CANADA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 206
TABLE 146 CANADA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2019–2026 (USD MILLION) 206
TABLE 147 CANADA: VETERINARY DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION) 207
10.3 EUROPE 207
TABLE 148 EUROPE: COMPANION POPULATION, 2019 (MILLION) 207
TABLE 149 EUROPE: LIVESTOCK POPULATION, 2019 (MILLION) 208
FIGURE 46 EU-27: LIVESTOCK POPULATION, 2012–2019 (MILLION) 208
TABLE 150 EUROPE: NUMBER OF VETERINARIANS, 2012–2019 209
TABLE 151 EUROPE: VETERINARY DIAGNOSTICS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 210
TABLE 152 EUROPE: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 210
TABLE 153 EUROPE: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 210
TABLE 154 EUROPE: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 211
TABLE 155 EUROPE: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 211
TABLE 156 EUROPE: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2019–2026 (USD MILLION) 211
TABLE 157 EUROPE: VETERINARY CLINICAL CHEMISTRY ANALYSIS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 212
TABLE 158 EUROPE: VETERINARY GLUCOSE MONITORING MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 212
TABLE 159 EUROPE: VETERINARY BLOOD GAS & ELECTROLYTE ANALYSIS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 212
TABLE 160 EUROPE: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 213
TABLE 161 EUROPE: VETERINARY HEMATOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 213
TABLE 162 EUROPE: VETERINARY URINALYSIS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 213
TABLE 163 EUROPE: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2019–2026 (USD MILLION) 214
TABLE 164 EUROPE: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS,
BY TYPE, 2019–2026 (USD MILLION) 214
TABLE 165 EUROPE: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2019–2026 (USD MILLION) 214
TABLE 166 EUROPE: VETERINARY DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION) 215
10.3.1 GERMANY 215
10.3.1.1 Rising awareness regarding zoonotic diseases to drive market growth 215
TABLE 167 GERMANY: COMPANION ANIMAL POPULATION, 2016–2019 (MILLION) 215
TABLE 168 GERMANY: LIVESTOCK ANIMAL POPULATION, 2016–2019 (MILLION) 216
TABLE 169 GERMANY: NUMBER OF VETERINARIANS, 2014 VS. 2019 216
TABLE 170 GERMANY: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 216
TABLE 171 GERMANY: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 217
TABLE 172 GERMANY: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 217
TABLE 173 GERMANY: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 217
TABLE 174 GERMANY: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2019–2026 (USD MILLION) 218
TABLE 175 GERMANY: VETERINARY CLINICAL CHEMISTRY ANALYSIS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 218
TABLE 176 GERMANY: VETERINARY GLUCOSE MONITORING MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 218
TABLE 177 GERMANY: VETERINARY BLOOD GAS & ELECTROLYTE ANALYSIS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 219
TABLE 178 GERMANY: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 219
TABLE 179 GERMANY: VETERINARY HEMATOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 219
TABLE 180 GERMANY: VETERINARY URINALYSIS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 220
TABLE 181 GERMANY: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2019–2026 (USD MILLION) 220
TABLE 182 GERMANY: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 220
TABLE 183 GERMANY: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2019–2026 (USD MILLION) 221
TABLE 184 GERMANY: VETERINARY DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION) 221
10.3.2 UK 221
10.3.2.1 The UK is the fastest-growing market for veterinary diagnostics in Europe 221
TABLE 185 UK: COMPANION ANIMAL POPULATION (2010–2019) (MILLION) 222
TABLE 186 UK: LIVESTOCK ANIMAL POPULATION, 2016–2019 (MILLION) 222
TABLE 187 UK: NUMBER OF VETERINARIANS, 2014 VS. 2019 222
TABLE 188 UK: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 223
TABLE 189 UK: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 223
TABLE 190 UK: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 223
TABLE 191 UK: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 224
TABLE 192 UK: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2019–2026 (USD MILLION) 224
TABLE 193 UK: VETERINARY CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 224
TABLE 194 UK: VETERINARY GLUCOSE MONITORING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 225
TABLE 195 UK: VETERINARY BLOOD GAS & ELECTROLYTE ANALYSIS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 225
TABLE 196 UK: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 225
TABLE 197 UK: VETERINARY HEMATOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 226
TABLE 198 UK: VETERINARY URINALYSIS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 226
TABLE 199 UK: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2019–2026 (USD MILLION) 226
TABLE 200 UK: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS,
BY TYPE, 2019–2026 (USD MILLION) 227
TABLE 201 UK: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE,
2019–2026 (USD MILLION) 227
TABLE 202 UK: VETERINARY DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION) 227
10.3.3 FRANCE 228
10.3.3.1 France is one of the leading markets for companion pet ownership 228
TABLE 203 FRANCE: COMPANION ANIMAL POPULATION, 2010–2019 (MILLION) 228
TABLE 204 FRANCE: LIVESTOCK ANIMAL POPULATION, 2016–2019 (MILLION) 229
TABLE 205 FRANCE: NUMBER OF VETERINARIANS, 2014 VS. 2017 229
TABLE 206 FRANCE: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 229
TABLE 207 FRANCE: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 230
TABLE 208 FRANCE: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 230
TABLE 209 FRANCE: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 230
TABLE 210 FRANCE: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2019–2026 (USD MILLION) 231
TABLE 211 FRANCE: VETERINARY CLINICAL CHEMISTRY ANALYSIS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 231
TABLE 212 FRANCE: VETERINARY GLUCOSE MONITORING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 231
TABLE 213 FRANCE: VETERINARY BLOOD GAS & ELECTROLYTE ANALYSIS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 232
TABLE 214 FRANCE: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 232
TABLE 215 FRANCE: VETERINARY HEMATOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 232
TABLE 216 FRANCE: VETERINARY URINALYSIS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 233
TABLE 217 FRANCE: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2019–2026 (USD MILLION) 233
TABLE 218 FRANCE: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS,
BY TYPE, 2019–2026 (USD MILLION) 233
TABLE 219 FRANCE: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2019–2026 (USD MILLION) 234
TABLE 220 FRANCE: VETERINARY DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION) 234

Lateral Flow Assay Components Market by Type, Application Type (Clinical Testing (Infectious, Cardiac Marker Test) Veterinary, Food Safety), Technique...

Publisher:        MarketsandMarkets

# of Pages:        224

Rating: 

1 User License $4,950

Publication Date:  April, 2022

Price:       $4,950 / User License




1 INTRODUCTION 33
1.1 OBJECTIVES OF THE STUDY 33
1.2 MARKET DEFINITION 33
1.2.1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 33
1.3 MARKET SCOPE 34
1.3.1 MARKETS COVERED 34
FIGURE 1 LATERAL FLOW ASSAY COMPONENTS MARKET SEGMENTATION 34
1.3.2 YEARS CONSIDERED FOR THE STUDY 35
1.4 CURRENCY 35
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 35
1.5 STAKEHOLDERS 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH APPROACH 36
FIGURE 2 RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 37
2.1.2 PRIMARY DATA 38
2.1.2.1 Primary sources 38
2.1.2.2 Key data from primary sources 39
2.1.2.3 Breakdown of primaries 39
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION 39
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 40
2.2 MARKET SIZE ESTIMATION 40
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021) 41
FIGURE 6 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 42
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 44
FIGURE 7 DATA TRIANGULATION METHODOLOGY 45
2.4 KEY INDUSTRY INSIGHTS 46
2.5 LIMITATIONS 46
2.5.1 METHODOLOGY-RELATED LIMITATIONS 46
2.6 RISK ASSESSMENT 47
2.7 ASSUMPTIONS FOR THE STUDY 47
 
3 EXECUTIVE SUMMARY 48
FIGURE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 48
FIGURE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2022 VS. 2027 (USD MILLION) 49
FIGURE 10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 50
FIGURE 11 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2022 VS. 2027 (USD MILLION) 51
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 52
4 PREMIUM INSIGHTS 53
4.1 LATERAL FLOW ASSAY COMPONENTS MARKET OVERVIEW 53
FIGURE 13 RISING NUMBER OF LOCAL MANUFACTURERS FOR COMPONENTS IS DRIVING THE GROWTH OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 53
4.2 REGIONAL MIX: LATERAL FLOW ASSAY COMPONENTS MARKET 54
FIGURE 14 APAC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 54
4.3 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE AND COUNTRY 55
FIGURE 15 MEMBRANES ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2021 55
4.4 LATERAL FLOW ASSAY COMPONENTS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 56
4.5 LATERAL FLOW ASSAY COMPONENTS MARKET: DEVELOPED VS. DEVELOPING COUNTRIES 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS: IMPACT ANALYSIS 57
5.2.1 DRIVERS 58
5.2.1.1 Growing demand for lateral flow assay kits due
to the COVID-19 pandemic 58
5.2.1.2 Growing usage of home-based lateral flow assay devices 58
5.2.1.3 Growing demand for point-of-care testing 58
5.2.1.4 Increasing public-private investments to develop lateral flow assays 59
5.2.2 RESTRAINTS 59
5.2.2.1 Availability of alternative diagnostic technologies 59
5.2.3 OPPORTUNITIES 59
5.2.3.1 Evolving applications of lateral flow assays 59
5.2.4 CHALLENGES 60
5.2.4.1 Requirement of specialized storage and shipping facilities for membranes 60
5.3 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES (YC-YCC) IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
FIGURE 16 YC–YCC SHIFT IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 61
5.5 AVERAGE SELLING PRICE TREND 61
TABLE 2 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAY COMPONENTS,
BY REGION, 2021 (USD) 61
5.6 ECOSYSTEM MARKET MAP 62
FIGURE 17 ECOSYSTEM: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 62
5.7 PATENT ANALYSIS 63
5.7.1 PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAYS 63
FIGURE 18 GLOBAL PATENT PUBLICATION TRENDS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2016–2021 64
5.7.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 64
FIGURE 19 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAYS COMPONENTS, 2016–2021 64
5.8 VALUE CHAIN ANALYSIS 65
5.9 REGULATORY LANDSCAPE 66
TABLE 3 REGULATORY STANDARDS/APPROVALS REQUIRED FOR LATERAL FLOW IMMUNOASSAY PRODUCTS, BY COUNTRY/REGION 66
5.9.1 NORTH AMERICA 66
5.9.2 EUROPE 67
5.9.3 ASIA PACIFIC 67
5.9.3.1 India 67
5.9.3.2 China 67
5.9.3.3 Japan 68
5.10 TECHNOLOGY ANALYSIS 69
5.10.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS 69
5.11 KEY CONFERENCES & EVENTS DURING 2021–2023 69
TABLE 4 LATERAL FLOW ASSAY COMPONENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 69
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 70
5.12.1 KEY STAKEHOLDERS IN THE BUYING PROCESS 70
FIGURE 20 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
TABLE 5 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
5.12.2 BUYING CRITERIA 71
FIGURE 21 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
TABLE 6 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
5.13 PORTER’S FIVE FORCES ANALYSIS 72
TABLE 7 LATERAL FLOW ASSAY COMPONENTS MARKET:
PORTER’S FIVE FORCES ANALYSIS 72
5.13.1 THREAT FROM NEW ENTRANTS 72
5.13.2 THREAT FROM SUBSTITUTES 72
5.13.3 BARGAINING POWER OF BUYERS 73
5.13.4 BARGAINING POWER OF SUPPLIERS 73
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 73
6 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE 74
6.1 INTRODUCTION 75
TABLE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 75
6.2 MEMBRANES 75
TABLE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE,
2020–2027 (USD MILLION) 76
TABLE 10 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 76
6.2.1 NITROCELLULOSE MEMBRANES 77
6.2.1.1 Advantages of nitrocellulose membranes such as high protein-binding affinity and compatibility with a wide range of detection methods to drive market growth 77
TABLE 11 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES, BY COUNTRY, 2020–2027 (USD MILLION) 77
TABLE 12 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (1 X 1 M SHEETS), BY REGION, 2020–2027 (IN THOUSANDS) 78
TABLE 13 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (20 MM X 1 M ROLLS), BY REGION, 2020–2027 (IN MILLIONS) 78
6.2.2 OTHER MEMBRANES 78
TABLE 14 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 79
6.3 PADS 80
TABLE 15 EXAMPLES OF DIFFERENT MATERIALS USED IN MANUFACTURING LATERAL FLOW ASSAY PADS 80
TABLE 16 LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 80
TABLE 17 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PADS, BY COUNTRY, 2020–2027 (USD MILLION) 81
6.3.1 SAMPLE PADS 81
6.3.1.1 Ability to promote even and controlled distribution of samples to drive market growth 81
TABLE 18 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SAMPLE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 82
6.3.2 CONJUGATE PADS 82
6.3.2.1 Conjugate pads play an important role in controlling the performance of lateral flow immunoassays 82
TABLE 19 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CONJUGATE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 83
6.3.3 ABSORBENT PADS 84
6.3.3.1 Absorbent pads prevent backflow—a key factor driving market growth 84
TABLE 20 LATERAL FLOW ASSAY COMPONENTS MARKET FOR ABSORBENT PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 84
6.4 OTHER COMPONENTS 84
TABLE 21 OTHER LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 85
7 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION 86
7.1 INTRODUCTION 87
TABLE 22 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 87
7.2 CLINICAL TESTING 87
TABLE 23 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 88
TABLE 24 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION) 88
7.2.1 INFECTIOUS DISEASE TESTING 89
7.2.1.1 Rising demand for infectious disease testing in emerging markets to drive market growth 89
TABLE 25 LATERAL FLOW ASSAY COMPONENTS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 89
7.2.2 PREGNANCY & FERTILITY TESTING 90
7.2.2.1 Growing infertility levels due to changing lifestyles—a key factor driving market growth 90
TABLE 26 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 90
7.2.3 CARDIAC MARKER TESTING 91
7.2.3.1 Rising prevalence of cardiovascular diseases and growing government support to drive growth in this market segment 91
TABLE 27 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 92
7.2.4 CHOLESTEROL TESTING/LIPID PROFILING 92
7.2.4.1 Growing prevalence of obesity and CVD—
a key factor driving market growth 92
TABLE 28 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CHOLESTEROL TESTING/LIPID PROFILING, BY COUNTRY, 2020–2027 (USD MILLION) 93
7.2.5 DRUGS-OF-ABUSE TESTING 93
7.2.5.1 Technological advancements and a growing focus on workplace
drug testing are driving market growth 93
TABLE 29 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 94
7.2.6 OTHER CLINICAL TESTING APPLICATIONS 94
TABLE 30 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER CLINICAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 95
7.3 VETERINARY DIAGNOSTICS 95
7.3.1 INFECTIOUS DISEASE OUTBREAKS (PARTICULARLY IN LARGE LIVESTOCK ANIMALS) TO DRIVE MARKET GROWTH 95
TABLE 31 LATERAL FLOW ASSAY COMPONENTS MARKET FOR VETERINARY DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 96
7.4 FOOD SAFETY & ENVIRONMENTAL TESTING 96
7.4.1 HIGH SENSITIVITY AND EASE OF USE ARE KEY FACTORS DRIVING THE DEMAND FOR LATERAL FLOW ASSAYS FOR FOOD SAFETY TESTING 96
TABLE 32 LATERAL FLOW ASSAY COMPONENTS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 97
7.5 DRUG DEVELOPMENT & QUALITY TESTING 97
7.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO DRIVE MARKET GROWTH IN THE COMING YEARS 97
TABLE 33 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 98
8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE 99
8.1 INTRODUCTION 100
TABLE 34 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 100
8.2 SANDWICH ASSAYS 100
8.2.1 SANDWICH ASSAYS PROVIDE HIGHER LEVELS OF ASSAY SENSITIVITY AND SPECIFICITY THAN OTHER ASSAY TECHNIQUES—A KEY FACTOR DRIVING GROWTH IN THIS MARKET SEGMENT 100
TABLE 35 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SANDWICH ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 101
8.3 COMPETITIVE ASSAYS 101
8.3.1 REDUCED SELECTIVITY AND SENSITIVITY OF COMPETITIVE ASSAYS IN RELATION TO SANDWICH ASSAYS COULD HAMPER MARKET GROWTH 101
TABLE 36 LATERAL FLOW ASSAY COMPONENTS MARKET FOR COMPETITIVE ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 102
8.4 MULTIPLEX DETECTION ASSAYS 102
8.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE MARKET GROWTH 102
TABLE 37 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2020–2027 (USD MILLION) 103
9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER 104
9.1 INTRODUCTION 105
TABLE 38 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 105
9.2 MEDICAL DEVICE MANUFACTURING COMPANIES 105
9.2.1 INCREASING USE OF POC TESTS IS DRIVING THE ADOPTION OF LATERAL FLOW ASSAY COMPONENTS AMONG MEDICAL DEVICE MANUFACTURING COMPANIES 105
TABLE 39 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE MANUFACTURING COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 106
9.3 MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES 106
9.3.1 GROWING INCLINATION TOWARD FAST AND EARLY DIAGNOSIS, ESPECIALLY IN RELATION TO THE CURRENT COVID-19 SCENARIO, WILL DRIVE MARKET GROWTH 106
TABLE 40 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES, BY COUNTRY,
2020–2027 (USD MILLION) 107
 
10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION 108
10.1 INTRODUCTION 109
FIGURE 22 CHINA TO REGISTER THE HIGHEST GROWTH IN THE LATERAL FLOW ASSAY COMPONENTS MARKET DURING THE FORECAST PERIOD 109
TABLE 41 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION,
2020–2027 (USD MILLION) 110
10.2 NORTH AMERICA 110
TABLE 42 NORTH AMERICA: MACROECONOMIC INDICATORS 110
FIGURE 23 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 111
TABLE 43 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 44 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 45 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 112
TABLE 46 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 113
TABLE 47 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 113
TABLE 48 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 49 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 114
TABLE 50 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 115
10.2.1 US 115
10.2.1.1 Increasing R&D investments and venture capital funding from both large and small firms towards the development of lateral flow assay diagnostics to drive market growth in the US 115
TABLE 51 US: MACROECONOMIC INDICATORS 116
TABLE 52 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 116
TABLE 53 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 116
TABLE 54 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 117
TABLE 55 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 117
TABLE 56 US: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 57 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 118
TABLE 58 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 119
10.2.2 CANADA 119
10.2.2.1 Lateral flow assay components market in Canada is estimated to grow at a relatively lower rate than the US 119
TABLE 59 CANADA: MACROECONOMIC INDICATORS 119
TABLE 60 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 120
TABLE 61 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 120
TABLE 62 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 120
TABLE 63 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121
TABLE 64 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 65 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 122
TABLE 66 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 122
10.3 EUROPE 122
TABLE 67 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 123
TABLE 68 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 123
TABLE 69 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 123
TABLE 70 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 124
TABLE 71 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 124
TABLE 72 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 73 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 125
TABLE 74 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 126
10.3.1 GERMANY 126
10.3.1.1 Growing demand for POC testing to drive the lateral flow assay components market in Germany 126
TABLE 75 GERMANY: MACROECONOMIC INDICATORS 126
TABLE 76 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 127
TABLE 77 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 127
TABLE 78 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 127
TABLE 79 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 128
TABLE 80 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 81 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 129
TABLE 82 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 129
10.3.2 FRANCE 129
10.3.2.1 High prevalence of age-related chronic diseases and infectious diseases to drive market growth in France 129
TABLE 83 FRANCE: MACROECONOMIC INDICATORS 130
TABLE 84 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 130
TABLE 85 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 130
TABLE 86 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 131
TABLE 87 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 131
TABLE 88 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 89 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 132
TABLE 90 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 133
10.3.3 UK 133
10.3.3.1 Severe impact of the second wave of COVID-19 in the first half of 2021 resulted in higher adoption of rapid COVID tests in the UK 133
TABLE 91 UK: MACROECONOMIC INDICATORS 134
TABLE 92 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 134
TABLE 93 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 134
TABLE 94 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 135
TABLE 95 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 135
TABLE 96 UK: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 97 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 136
TABLE 98 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 137
10.3.4 ITALY 137
10.3.4.1 Growing initiatives towards decentralization of medical services in Italy are contributing to the market growth in the country 137
TABLE 99 ITALY: MACROECONOMIC INDICATORS 137
TABLE 100 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 138
TABLE 101 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 138
TABLE 102 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 138
TABLE 103 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 139
TABLE 104 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 105 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 140
TABLE 106 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 140
10.3.5 SPAIN 140
10.3.5.1 Increasing focus of international organizations and domestic players on the development of POC products in the country to drive market growth 140
TABLE 107 SPAIN: MACROECONOMIC INDICATORS 141
TABLE 108 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 141
TABLE 109 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 142
TABLE 110 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 142
TABLE 111 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 142
TABLE 112 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 113 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 143
TABLE 114 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 144
10.3.6 REST OF EUROPE 144
TABLE 115 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 144
TABLE 116 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 145
TABLE 117 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 145
TABLE 118 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 145
TABLE 119 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 120 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 146
TABLE 121 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 147
10.4 ASIA PACIFIC 147
FIGURE 24 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 148
TABLE 122 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 149
TABLE 123 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 149
TABLE 124 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 149
TABLE 125 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 150
TABLE 126 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 150
TABLE 127 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 128 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 151
TABLE 129 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 152
10.4.1 CHINA 152
10.4.1.1 Higher exports of lateral flow assay components during the COVID-19 pandemic to drive market growth in the country 152
TABLE 130 CHINA: MACROECONOMIC INDICATORS 153
TABLE 131 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 153
TABLE 132 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 153
TABLE 133 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 154
TABLE 134 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 154
TABLE 135 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 136 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 155
TABLE 137 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 156
10.4.2 JAPAN 156
10.4.2.1 Increasing prevalence of age-related illnesses driving the growth of the lateral flow assay components market in Japan 156
TABLE 138 JAPAN: MACROECONOMIC INDICATORS 157
TABLE 139 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 157
TABLE 140 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 157
TABLE 141 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 158
TABLE 142 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
TABLE 143 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 144 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 159
TABLE 145 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 160
10.4.3 INDIA 160
10.4.3.1 Increasing number of local manufacturers, growing healthcare concerns, and rising income levels to propel the growth of this market 160
TABLE 146 INDIA: MACROECONOMIC INDICATORS 160
TABLE 147 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 161
TABLE 148 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 161
TABLE 149 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 161
TABLE 150 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 162
TABLE 151 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 152 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 163
TABLE 153 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 163
10.4.4 AUSTRALIA 164
10.4.4.1 Increasing prevalence of infectious diseases, especially influenza, to drive the growth of the lateral flow assay components market in Australia 164
TABLE 154 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 164
TABLE 155 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 164
TABLE 156 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 165
TABLE 157 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 165
TABLE 158 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 159 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 166
TABLE 160 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 167
10.4.5 REST OF ASIA PACIFIC 167
TABLE 161 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 167
TABLE 162 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 168
TABLE 163 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 168
TABLE 164 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 168
TABLE 165 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 166 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 169
TABLE 167 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 170
 
10.5 LATIN AMERICA 170
10.5.1 HIGH DEMAND FOR HIV POC DEVICES IN THE REGION TO SUPPORT THE GROWTH OF THE MARKET 170
TABLE 168 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 169 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 171
TABLE 170 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD
TYPE, 2020–2027 (USD MILLION) 171
TABLE 171 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 172
TABLE 172 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 173 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 173
TABLE 174 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 173
10.6 MIDDLE EAST & AFRICA 173
10.6.1 SIGNIFICANT SUPPORT FROM GOVERNMENTS AND GLOBAL FIRMS TOWARDS EXPANDING HEALTHCARE SERVICES DRIVES THE ADOPTION OF LATERAL FLOW ASSAYS 173
TABLE 175 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 174
TABLE 176 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 177 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 175
TABLE 178 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 175
TABLE 179 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 175
TABLE 180 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 181 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 176
TABLE 182 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 177
11 COMPETITIVE LANDSCAPE 178
11.1 OVERVIEW 178
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 178
FIGURE 25 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
11.3 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
FIGURE 26 REVENUE SHARE ANALYSIS FOR THE KEY PLAYERS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 180
11.4 MARKET SHARE ANALYSIS 180
FIGURE 27 LATERAL FLOW ASSAY COMPONENTS MARKET SHARE ANALYSIS, BY KEY PLAYER (2021) 181
TABLE 183 LATERAL FLOW ASSAY COMPONENTS MARKET: DEGREE OF COMPETITION 182
11.5 R&D ASSESSMENT OF KEY PLAYERS 183
FIGURE 28 R&D EXPENDITURE: MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2018 VS. 2020 183
11.6 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS 183
FIGURE 29 GEOGRAPHIC REVENUE ASSESSMENT: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 184
11.7 COMPANY EVALUATION QUADRANT 184
11.7.1 STARS 184
11.7.2 PERVASIVE PLAYERS 184
11.7.3 EMERGING LEADERS 185
11.7.4 PARTICIPANTS 185
FIGURE 30 LATERAL FLOW ASSAY COMPONENTS MARKET: COMPANY EVALUATION MATRIX, 2021 185
11.8 COMPETITIVE BENCHMARKING 186
11.8.1 OVERALL COMPANY FOOTPRINT 186
TABLE 184 OVERALL COMPANY FOOTPRINT (17 COMPANIES) 186
TABLE 185 COMPANY FOOTPRINT: BY TYPE (17 COMPANIES) 187
TABLE 186 COMPANY FOOTPRINT: BY REGION (17 COMPANIES) 188
11.9 COMPETITIVE SCENARIO 188
11.9.1 DEALS 189
TABLE 187 DEALS, JANUARY 2019–FEBRUARY 2022 189
11.9.2 OTHER DEVELOPMENTS 189
TABLE 188 OTHER DEVELOPMENTS, JANUARY 2019–FEBRUARY 2022 189
12 COMPANY PROFILES 190
12.1 KEY PLAYERS 190
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 DANAHER CORPORATION (PALL CORPORATION AND CYTIVA LIFE SCIENCE) 190
TABLE 189 DANAHER CORPORATION: BUSINESS OVERVIEW 190
FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 191
12.1.2 SARTORIUS STEDIM BIOTECH 195
TABLE 190 SARTORIUS STEDIM BIOTECH: BUSINESS OVERVIEW 195
12.1.3 MERCK KGAA 199
TABLE 191 MERCK KGAA: BUSINESS OVERVIEW 199
FIGURE 33 MERCK KGAA: COMPANY SNAPSHOT (2020) 200
12.1.4 AHLSTROM-MUNKSJÖ 204
TABLE 192 AHLSTROM-MUNKSJÖ: BUSINESS OVERVIEW 204
FIGURE 34 AHLSTROM-MUNKSJÖ: COMPANY SNAPSHOT (2020) 205
12.1.5 ADVANCED MICRODEVICES PVT. LTD. 208
TABLE 193 ADVANCED MICRODEVICES PVT. LTD.: BUSINESS OVERVIEW 208
12.1.6 DCN DIAGNOSTICS 210
TABLE 194 DCN DIAGNOSTICS: BUSINESS OVERVIEW 210
12.2 OTHER PLAYERS 211
12.2.1 FORTIS LIFE SCIENCES 211
TABLE 195 FORTIS LIFE SCIENCES: BUSINESS OVERVIEW 211
12.2.2 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD 212
TABLE 196 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD.:
BUSINESS OVERVIEW 212
12.2.3 AXIVA SICHEM BIOTECH 214
TABLE 197 AXIVA SICHEM BIOTECH: BUSINESS OVERVIEW 214
12.2.4 NUPORE FILTRATION SYSTEM 216
TABLE 198 NUPORE FILTRATION SYSTEM: BUSINESS OVERVIEW 216
12.2.5 BALLYA BIO 217
TABLE 199 BALLYA BIO: BUSINESS OVERVIEW 217
12.2.6 RUNBIO BIOTECH CO. LTD. 219
TABLE 200 RUNBIO BIOTECH CO. LTD.: BUSINESS OVERVIEW 219
12.2.7 NEENAH GESSNER 220
TABLE 201 NEENAH GESSNER: BUSINESS OVERVIEW 220
12.2.8 MAXIM BIOMEDICAL 221
TABLE 202 MAXIM BIOMEDICAL: BUSINESS OVERVIEW 221
12.2.9 CYTODIAGNOSTICS 222
TABLE 203 CYTODIAGNOSTICS: BUSINESS OVERVIEW 222
12.2.10 SENOVA GMBH 223
TABLE 204 SENOVA GMBH: BUSINESS OVERVIEW 223
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 224
13.1 DISCUSSION GUIDE 224
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 229
13.3 AVAILABLE CUSTOMIZATIONS 231
13.4 RELATED REPORTS 231
13.5 AUTHOR DETAILS 232

US Healthcare Environmental Services Market by Type (Janitorial/Core-Cleaning, Infection Control & Prevention, Front-of-house cleaning & Brand Experie...

Publisher:        MarketsandMarkets

# of Pages:        126

Rating: 

1 User License $4,950

Publication Date:  March, 2022

Price:       $4,950 / User License




1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION & SCOPE 15
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 16
1.2.2 MARKET SEGMENTATION 16
FIGURE 1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET SEGMENTATION 16
1.2.3 YEARS CONSIDERED FOR THE STUDY 17
1.3 CURRENCY 17
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 17
1.4 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH APPROACH 19
FIGURE 2 RESEARCH DESIGN 19
2.1.1 SECONDARY RESEARCH 20
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY RESEARCH 21
FIGURE 3 PRIMARY SOURCES 22
2.1.2.1 Key data from primary sources 23
2.1.2.2 Insights from primary experts 23
2.1.2.3 Breakdown of primary interviews 24
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE (SUPPLY & DEMAND SIDE) AND DESIGNATION 24
2.2 MARKET SIZE ESTIMATION 25
FIGURE 5 MARKET SIZE APPROACH – REVENUE SHARE ANALYSIS 25
FIGURE 6 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 26
FIGURE 7 DEMAND-SIDE APPROACH 28
2.3 DATA TRIANGULATION 29
FIGURE 8 DATA TRIANGULATION METHODOLOGY 29
2.4 MARKET RANKING ANALYSIS 30
2.5 ASSUMPTIONS FOR THE STUDY 30
2.6 LIMITATIONS 31
2.6.1 METHODOLOGY-RELATED LIMITATIONS 31
2.6.2 SCOPE-RELATED LIMITATIONS 31
2.7 RISK ASSESSMENT 31
TABLE 2 RISK ASSESSMENT: US HEALTHCARE ENVIRONMENTAL SERVICES MARKET 31
 
3 EXECUTIVE SUMMARY 32
FIGURE 9 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 32
FIGURE 10 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET,
BY FACILITY TYPE, 2021 VS. 2026 (USD MILLION) 33
4 PREMIUM INSIGHTS 34
4.1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET OVERVIEW 34
FIGURE 11 STRINGENT REGULATORY GUIDELINES ON INFECTION CONTROL & PREVENTION METHODS IS A KEY FACTOR DRIVING THE MARKET GROWTH 34
4.2 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE AND FACILITY TYPE 35
FIGURE 12 JANITORIAL/CORE-CLEANING SERVICES ACCOUNTED FOR THE LARGEST SHARE OF THE US HEALTHCARE ENVIRONMENTAL SERVICES
MARKET IN 2020 35
4.3 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE (2021–2026) 36
FIGURE 13 ACUTE CARE FACILITIES TO DOMINATE THE US HEALTHCARE ENVIRONMENTAL SERVICES MARKET DURING THE FORECAST PERIOD 36
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS 37
TABLE 3 MARKET DYNAMICS: HEALTHCARE ENVIRONMENTAL SERVICES MARKET 37
5.2.1 MARKET DRIVERS 38
5.2.1.1 Increasing prevalence of Hospital-acquired infections (HAIs) 38
5.2.1.2 Rising number of hospital admissions and surgeries 39
TABLE 4 US: PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED 39
FIGURE 14 TOTAL ADMISSIONS IN ALL US HOSPITALS 40
FIGURE 15 TOTAL NUMBER OF HOSPITALS IN THE US 40
5.2.1.3 Shortage of in-house expertise and the rising need to reduce healthcare costs 41
5.2.1.4 Increasing outsourcing of cleaning services 41
5.2.2 MARKET RESTRAINTS 41
5.2.2.1 Healthcare facilities with an in-house EVS department 41
5.2.3 MARKET OPPORTUNITIES 42
5.2.3.1 Sustained acquisitions among strategic & financial buyers 42
TABLE 5 COMPANY ACQUISITIONS 42
5.2.4 MARKET CHALLENGES 42
5.2.4.1 Noncompliance with cleaning standards by EVS providers 42
5.3 INDUSTRY TRENDS 43
5.3.1 EMERGENCE OF NEW SURFACE DISINFECTANTS &
GREEN CLEANING PRODUCTS 43
5.3.2 DISINFECTION ROBOTS 44
5.3.3 MONITORING TOOLS FOR CLEANING QUALITY ASSESSMENT 44
5.4 TECHNOLOGY ANALYSIS 45
TABLE 6 TECHNOLOGY INNOVATION IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 45
5.5 PATENT ANALYSIS 45
5.5.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE ENVIRONMENTAL SERVICES 46
FIGURE 16 PATENT PUBLICATION TRENDS (JANUARY 2011–DECEMBER 2021) 46
5.5.2 JURISDICTION AND TOP APPLICANT ANALYSIS 47
FIGURE 17 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 47
FIGURE 18 TOP APPLICANT COUNTRIES/REGIONS FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 48
TABLE 7 LIST OF PATENTS/PATENT APPLICATIONS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET, 2020–2021 48
5.6 IMPACT OF COVID-19 ON THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 50
6 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE 51
6.1 INTRODUCTION 52
TABLE 8 US: HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 52
6.2 JANITORIAL SERVICES/CORE-CLEANING SERVICES 52
6.2.1 MANDATORY REGULAR CLEANING AND DISINFECTION OF HEALTHCARE FACILITIES TO DRIVE THE MARKET GROWTH 52
6.3 INFECTION PREVENTION & CONTROL SERVICES 53
TABLE 9 US: INFECTION PREVENTION & CONTROL SERVICE MARKET, BY TYPE,
2019–2026 (USD MILLION) 53
6.3.1 SPECIALIZED CLEANING SERVICES 53
6.3.1.1 Rising adoption of specialized services to reduce HAIs to drive the market growth 53
6.3.2 INFECTION PREVENTION & CONTROL CONSULTATION SERVICES 53
6.3.2.1 The provision of customized environmental services specific
to a healthcare facility ensures market demand 53
6.4 ENHANCED CLEANING TECHNOLOGY 54
6.4.1 RISING DEMAND FOR ADVANCED CLEANING SOLUTIONS TO DRIVE THE SEGMENT GROWTH 54
TABLE 10 EXAMPLES OF COMPANIES PROVIDING TECHNOLOGY & INNOVATION IN HEALTHCARE EVS 54
6.5 FRONT-OF-HOUSE CLEANING AND BRAND EXPERIENCE 56
6.5.1 RISING AWARENESS TOWARDS A CLEAN AND SAFE ENVIRONMENT DURING PANDEMICS TO SUSTAIN THE MARKET GROWTH 56
6.6 OTHER SERVICES 56
 
7 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE 57
7.1 INTRODUCTION 58
FIGURE 19 STATES WITH THE HIGHEST NUMBER OF COVID-19 ADMISSIONS
(FEBRUARY 2022) 58
TABLE 11 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE, 2019–2026 (USD MILLION) 59
7.2 ACUTE-CARE FACILITIES 59
TABLE 12 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR ACUTE-CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 59
7.2.1 ACUTE HOSPITALS 60
7.2.1.1 Increasing hospital admissions due to COVID-19 and the rising prevalence of HAIs propel the market growth 60
FIGURE 20 NUMBER OF HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS
IN THE US (2020) 60
FIGURE 21 HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS IN THE US (2020) 61
FIGURE 22 HAIS REPORTED BY CRITICAL ACCESS HOSPITALS (CAHS) IN THE US (2018) 61
7.2.2 MILITARY TREATMENT FACILITY 61
7.2.2.1 The increasing number of military ambulatory health services & funding to drive the market growth 61
FIGURE 23 MILITARY HEALTH SYSTEMS FACILITIES IN THE US (2021) 62
7.2.3 CHILDREN’S HOSPITALS 62
7.2.3.1 Rising cases of COVID-19 and infection-related mortality rates among children drive the market growth 62
7.2.4 AMBULATORY SURGERY CENTERS (ASCS) 63
7.2.4.1 ASCs save time and reduce the risk of HAIS; key factor driving the market growth 63
FIGURE 24 US SURGERY CASES BY SETTING: ASC VS. HOPD (2005-2020) 64
7.2.5 ACADEMIC MEDICAL CENTERS (AMCS) 64
7.2.5.1 Healthcare capacity expansion during COVID-19 drives the adoption of healthcare environmental services in AMCs 64
7.3 POST-ACUTE CARE FACILITIES 64
TABLE 13 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR POST-ACUTE CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 65
7.3.1 LONG-TERM ACUTE HOSPITALS (LTACH) 65
7.3.1.1 Increasing risk of infection due to prolonged hospital stays to drive the market growth 65
7.3.2 SKILLED NURSING FACILITIES (SNF) 66
7.3.2.1 Increasing admissions of elderly people in skilled nursing facilities to drive the market growth 66
7.3.3 OTHER POST-ACUTE CARE FACILITIES 66
7.4 NON-ACUTE CARE FACILITIES 67
TABLE 14 US: ENVIRONMENTAL SERVICES MARKET FOR NON-ACUTE CARE SETTINGS, BY TYPE, 2019–2026 (USD MILLION) 67
7.4.1 PHYSICIAN’S OFFICES AND CLINICS 67
7.4.1.1 High patient traffic leads to continuous cleaning & maintenance to drive the market growth 67
7.4.2 OTHER NON-ACUTE CARE FACILITIES 68
FIGURE 25 DISTRIBUTION OF INDUSTRY MEDICAL AND HEALTH R&D INVESTMENTS,
BY SEGMENT (2020) 68
8 COMPETITIVE LANDSCAPE 70
8.1 OVERVIEW 70
8.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 70
8.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 71
8.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 72
8.4 MARKET RANKING ANALYSIS 73
FIGURE 27 US HEALTHCARE ENVIRONMENTAL SERVICE MARKET RANKING,
BY KEY PLAYER, 2020 73
8.5 COMPETITIVE BENCHMARKING 75
TABLE 15 FOOTPRINT OF COMPANIES IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 75
TABLE 16 SERVICE FOOTPRINT OF COMPANIES 76
TABLE 17 END-USER FOOTPRINT OF COMPANIES 77
8.6 COMPETITIVE LEADERSHIP MAPPING 77
8.6.1 STARS 78
8.6.2 EMERGING LEADERS 78
8.6.3 PERVASIVE PLAYERS 78
8.6.4 PARTICIPANTS 78
FIGURE 28 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET:
COMPETITIVE LEADERSHIP MAPPING (2021) 79
8.7 COMPETITIVE SCENARIO 80
8.7.1 SERVICE APPROVALS/ENHANCEMENTS 80
8.7.2 DEALS 81
TABLE 19 DEALS, 2018–2022 81
8.7.3 OTHER DEVELOPMENTS 82
9 COMPANY PROFILES 83
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
9.1 SODEXO GLOBAL 83
TABLE 21 SODEXO GLOBAL: BUSINESS OVERVIEW 83
FIGURE 29 SODEXO GLOBAL: COMPANY SNAPSHOT (2021) 84
9.2 COMPASS GROUP (CROTHALL HEALTHCARE (US)) 87
TABLE 22 COMPASS GROUP: BUSINESS OVERVIEW 87
FIGURE 30 COMPASS GROUP: COMPANY SNAPSHOT (2021) 88
 
9.3 ARAMARK CORPORATION 90
TABLE 23 ARAMARK CORPORATION: BUSINESS OVERVIEW 90
FIGURE 31 ARAMARK CORPORATION: COMPANY SNAPSHOT (2021) 91
9.4 HOSPITAL HOUSEKEEPING SYSTEMS (HHS) (US) 94
TABLE 24 HOSPITAL HOUSEKEEPING SYSTEMS (HHS): BUSINESS OVERVIEW 94
9.5 HEALTHCARE SERVICES GROUP, INC. 97
TABLE 25 HEALTHCARE SERVICES GROUP, INC.: BUSINESS OVERVIEW 97
FIGURE 32 HEALTHCARE SERVICES GROUP: COMPANY SNAPSHOT (2020) 98
9.6 ABM INDUSTRIES INCORPORATED 100
TABLE 26 ABM INDUSTRIES INCORPORATED: BUSINESS OVERVIEW 100
FIGURE 33 ABM INDUSTRIES INCORPORATED: COMPANY SNAPSHOT (2020) 101
9.7 OCTOCLEAN 103
TABLE 27 OCTOCLEAN: BUSINESS OVERVIEW 103
9.8 SERVICEMASTER CLEAN (SERVICEMASTER TBS) 105
TABLE 28 SERVICEMASTER CLEAN.: BUSINESS OVERVIEW 105
9.9 CORVUS JANITORIAL SYSTEMS 107
TABLE 29 CORVUS JANITORIAL SYSTEMS: BUSINESS OVERVIEW 107
9.10 BRAVO! BUILDING SERVICES 109
TABLE 30 BRAVO! BUILDING SERVICES: BUSINESS OVERVIEW 109
9.11 POWERLINK ENVIRONMENTAL SERVICES, LLC 111
TABLE 31 POWERLINK ENVIRONMENTAL SERVICES, LLC: BUSINESS OVERVIEW 111
9.12 JANI-KING INTERNATIONAL, INC. 112
TABLE 32 JANI- KING INTERNATIONAL, INC: BUSINESS OVERVIEW 112
9.13 AVI FOOD SYSTEMS(US) 114
TABLE 33 AVI FOOD SYTEMS, INC.: BUSINESS OVERVIEW 114
9.14 SERVICON 115
TABLE 34 SERVICON: BUSINESS OVERVIEW 115
9.15 XANITOS, INC. 117
TABLE 35 XANITOS, INC.: BUSINESS OVERVIEW 117
9.16 STATHAKIS 119
TABLE 36 STATHAKIS: BUSINESS OVERVIEW 119
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
10 APPENDIX 120
10.1 INSIGHTS FROM INDUSTRY EXPERTS 120
10.2 DISCUSSION GUIDE 121
10.3 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 124
10.4 AVAILABLE CUSTOMIZATIONS 126
10.5 RELATED REPORTS 126
10.6 AUTHOR DETAILS 127